06.12.2016
- Despite tremendous challenges facing the pharmaceutical industry, it continues with its commitment to innovation and the discovery of novel drugs to address unmet medical needs...
05.10.2016
- US life sciences company Cambrex has completed and validated a new pilot plant at its manufacturing and R&D site in Paullo, Milan, Italy. Built to meet customer demand for small...
27.09.2016
- In a move to boost its portfolio of small molecule API services, US-based life sciences company Cambrex has agreed to buy PharmaCore for $25 million. With 60 employees, PharmaCore...
16.09.2016
- Cambrex, the leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs), has announced a SEK 72 million ($9 million) investment to expand...
Growth in the global oncology drug market is an important measure of opportunities in drug development and manufacturing, including for contract manufacturers of active...
08.09.2016
- Despite tremendous challenges facing the pharmaceutical industry, it continues with its commitment to innovation and the discovery of novel drugs to address unmet medical needs...
30.05.2011
- Analysis - When comparing the fine chemicals market of today to that of 2001, a few clear differences can be seen. Fine chemicals expert Jan Ramakers takes an in-depth look at the...
